Tatsis Ourania 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed Feb 28, 2025
Insider Transaction Report
Form 4
Tatsis Ourania
EVP, Chief Reg. & Quality Off.
Transactions
- Sale
Common Stock
2025-02-27$475.34/sh−530$251,930→ 58,539 total - Tax Payment
Common Stock
2025-02-26$479.61/sh−4,962$2,379,825→ 59,069 total
Footnotes (1)
- [F1]Transaction made pursuant to Dr. Tatsis' company approved trading plan under Rule 10b5-1, which was entered into on 02/29/2024.